|
Sign In to gain access to subscriptions and/or personal tools.
|
Serotonin autoreceptor function and antidepressant drug action
S. Hjorth
Institute for Physiology and Pharmacology Department of Pharmacology, Göteborg University, Göteborg, Sweden; stephan.hjorth{at}pharm.gu.se
H. J. Bengtsson
A. Kullberg
D. Carlzon
H. Peilot
Institute for Physiology and Pharmacology, Department of Pharmacology, Göteborg University, Göteborg, Sweden
S. B. Auerbach
Department of Biological Sciences, Rutgers University, Piscataway, NJ, USA
This article briefly summarizes, within the context of a brief review of the relevant literature, the outcome of our recent rat microdialysis studies on (1) the relative importance of serotonin (5-HT)1A versus 5-HT1B autoreceptors in the mechanism of action of 5-HT reuptake blocking agents, including putative regional differences in this regard, and (2) autoreceptor responsiveness following chronic SSRI administration. First, our data are consistent with the primacy of 5-HT1A autoreceptors in restraining the elevation of 5-HT levels induced by SSRIs, whereas nerve terminal 5-HT1B autoreceptors appear to have an accessory role in this regard. Second, there is an important interplay between cell body and nerve terminal 5-HT autoreceptors, and recent findings suggest that this interplay may potentially be exploited to obtain regionally preferential effects on 5-HT neurotransmission in the central nervous system, even upon systemic drug administration. In particular, emerging data suggest that somatodendritic 5-HT1A autoreceptorand nerve terminal 5-HT1B autoreceptor-mediated feedback may be relatively more important in the control of 5-HT output in dorsal raphe-frontal cortex and median raphe-dorsal hippocampus systems, respectively. Third, 5-HT autoreceptors evidently retain the capability to limit the 5-HT transmission-promoting effect of SSRIs after chronic treatment. Thus, although the responsiveness of these sites is probably somewhat reduced, residual autoreceptor capacity still remains an effective restraint on large increases in extracellular 5-HT, even after prolonged treatment. If a further increase in extracellular 5-HT is crucial to the remission of depression in patients responding only partially to prolonged administration of antidepressants, then sustained adjunctive treatment with autoreceptor-blocking drugs may consequently prove useful in the long term.
Key Words: antidepressants • autoreceptors • CNS • 5-HT • 5-HT1A • 5-HT1B • microdialysis, rat
Journal of Psychopharmacology, Vol. 14, No. 2,
177-185 (2000)
DOI: 10.1177/026988110001400208
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
Z. Xie and G. M. Miller
{beta}-Phenylethylamine Alters Monoamine Transporter Function via Trace Amine-Associated Receptor 1: Implication for Modulatory Roles of Trace Amines in Brain
J. Pharmacol. Exp. Ther.,
May 1, 2008;
325(2):
617 - 628.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Xie, S. V. Westmoreland, and G. M. Miller
Modulation of Monoamine Transporters by Common Biogenic Amines via Trace Amine-Associated Receptor 1 and Monoamine Autoreceptors in Human Embryonic Kidney 293 Cells and Brain Synaptosomes
J. Pharmacol. Exp. Ther.,
May 1, 2008;
325(2):
629 - 640.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Barton, M. D. Esler, T. Dawood, E. A. Lambert, D. Haikerwal, C. Brenchley, F. Socratous, J. Hastings, L. Guo, G. Wiesner, et al.
Elevated Brain Serotonin Turnover in Patients With Depression: Effect of Genotype and Therapy
Arch Gen Psychiatry,
January 1, 2008;
65(1):
38 - 46.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. P. Guiard, J.-P. Guilloux, C. Reperant, S. P. Hunt, M. Toth, and A. M. Gardier
Substance P Neurokinin 1 Receptor Activation within the Dorsal Raphe Nucleus Controls Serotonin Release in the Mouse Frontal Cortex
Mol. Pharmacol.,
December 1, 2007;
72(6):
1411 - 1418.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Ferrie, A. H. Young, and R. McQuade
Effect of chronic lithium and withdrawal from chronic lithium on presynaptic dopamine function in the rat
J Psychopharmacol,
May 1, 2005;
19(3):
229 - 234.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. R. Albert and S. Lemonde
5-HT1A Receptors, Gene Repression, and Depression: Guilt by Association
Neuroscientist,
December 1, 2004;
10(6):
575 - 593.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. Weikop, J. Kehr, and J. Scheel-Kruger
The Role of {alpha}1- and {alpha}2-Adrenoreceptors on Venlafaxineinduced Elevation of Extracellular Serotonin, Noradrenaline and Dopamine Levels in the Rat Prefrontal Cortex and Hippocampus
J Psychopharmacol,
September 1, 2004;
18(3):
395 - 403.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. E. Page, J. F. Cryan, A. Sullivan, A. Dalvi, B. Saucy, D. R. Manning, and I. Lucki
Behavioral and Neurochemical Effects of 5-{4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide (EMD 68843): A Combined Selective Inhibitor of Serotonin Reuptake and 5-Hydroxytryptamine1A Receptor Partial Agonist
J. Pharmacol. Exp. Ther.,
September 1, 2002;
302(3):
1220 - 1227.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z.-Y. Zhang, B. M. King, N. N. Mollova, and Y. N. Wong
In Vitro Interactions between a Potential Muscle Relaxant E2101 and Human Cytochromes P450
Drug Metab. Dispos.,
July 1, 2002;
30(7):
805 - 813.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Knobelman, R. Hen, and I. Lucki
Genetic Regulation of Extracellular Serotonin by 5-Hydroxytryptamine1A and 5-Hydroxytryptamine1B Autoreceptors in Different Brain Regions of the Mouse
J. Pharmacol. Exp. Ther.,
September 1, 2001;
298(3):
1083 - 1091.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Knobelman, R. Hen, J. A. Blendy, and I. Lucki
Regional Patterns of Compensation following Genetic Deletion of Either 5-Hydroxytryptamine1A or 5-Hydroxytryptamine1B Receptor in the Mouse
J. Pharmacol. Exp. Ther.,
September 1, 2001;
298(3):
1092 - 1100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
